九安医疗：已回购1022.87万股，使用资金总额4.11亿元

Core Viewpoint - The company has announced a share repurchase plan with a total funding amount between 300 million and 600 million yuan, aiming to enhance shareholder value and stabilize stock prices [1] Group 1: Share Repurchase Plan - The company will hold its sixth board meeting on October 13, 2025, to review and approve the share repurchase proposal [1] - The funding for the repurchase will come from the company's own funds and special loan funds [1] - The maximum repurchase price is set at 53.5 yuan per share, with the actual number of shares repurchased to be determined by the end of the repurchase period [1] Group 2: Current Repurchase Status - As of November 21, 2025, the company has repurchased a total of 10.2287 million shares, accounting for 2.20% of the total share capital [1] - The repurchase price range has been between 39.598 yuan and 41.3 yuan per share, with a total expenditure of 411 million yuan (excluding transaction fees) [1]